Ignite Creation Date:
2025-12-25 @ 3:17 AM
Ignite Modification Date:
2026-03-29 @ 8:05 AM
Study NCT ID:
NCT00556205
Status:
WITHDRAWN
Last Update Posted:
2016-03-24
First Post:
2007-11-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma
Sponsor:
Massachusetts General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
07-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None